Duley Rumanveer Singh, Birdi Gurkiran Kaur, Bush Joseph, Connolly Derek, Shoaib Ahmad, Maidment Ian
Aston University, Birmingham, UK
Aston University, Birmingham, UK.
BMJ Open. 2025 Mar 24;15(3):e094168. doi: 10.1136/bmjopen-2024-094168.
Cardiovascular disease (CVD) remains a major public health issue in the United Kingdom (UK) and disproportionately affects minority ethnic groups who face higher rates of CVD, necessitating targeted interventions to address their specific health needs. Community pharmacies are accessible healthcare hubs that could address CVD and associated health inequalities. However, more promotion and research are needed to effectively reach deprived and hard-to-reach groups. Understanding the role of community pharmacies in preventing CVD in minority ethnic groups, including barriers and facilitators, is essential to improve their use in meeting this inequity. The objective of this review is to review the published literature to understand the potential role of community pharmacy in the prevention of CVD in minority ethnic groups, including barriers and facilitators.
A comprehensive literature search of Medline, EMBASE, PubMed, Scopus, Web Of Science and The Cumulative Index to Nursing and Allied Health Literature to identify published primary studies reporting on the role of community pharmacy in the prevention of CVD in minority ethnic groups including barriers and facilitators will be conducted (conducted 30 September 2024-2 October 2024). Backward and forward citation tracking will be conducted to identify further studies of relevance. Additionally, OpenGrey and Google Scholar searches will be conducted to identify unpublished studies. The mixed methods appraisal tool will be employed to assess study quality. Data will be extracted using a piloted data extraction form, adapted from the National Institute for Health and Care Excellence evidence table for qualitative studies. Reporting will be in line with enhancing transparency in reporting the synthesis of qualitative research (ENTREQ) guidelines.
Ethics approval is not required for systematic reviews of published literature. The review will be published in a peer-reviewed journal. The findings of this review will be combined with those of the future research and will be disseminated as guidance for members of ethnic minority groups and as recommendations for healthcare professionals and policy makers.
CRD42024579766.
心血管疾病（CVD）仍是英国的一个主要公共卫生问题，对少数族裔群体的影响尤为严重，这些群体面临着更高的心血管疾病发病率，因此需要有针对性的干预措施来满足他们的特定健康需求。社区药房是可及的医疗保健中心，可以解决心血管疾病及相关的健康不平等问题。然而，需要更多的推广和研究才能有效地覆盖贫困和难以接触到的群体。了解社区药房在预防少数族裔群体心血管疾病方面的作用，包括障碍和促进因素，对于提高其在解决这一不平等问题中的应用至关重要。本综述的目的是回顾已发表的文献，以了解社区药房在预防少数族裔群体心血管疾病方面的潜在作用，包括障碍和促进因素。
将对Medline、EMBASE、PubMed、Scopus、Web of Science和护理及联合健康文献累积索引进行全面的文献检索（检索时间为2024年9月30日至2024年10月2日），以识别已发表的关于社区药房在预防少数族裔群体心血管疾病方面的作用（包括障碍和促进因素）的原始研究。将进行反向和正向引文追踪以识别更多相关研究。此外，将对OpenGrey和谷歌学术进行检索以识别未发表的研究。将使用混合方法评估工具来评估研究质量。将使用一份经过试点的数据提取表来提取数据，该表改编自英国国家卫生与临床优化研究所的定性研究证据表。报告将符合提高定性研究综合报告透明度（ENTREQ）指南。
对已发表文献的系统综述无需伦理批准。本综述将发表在同行评审期刊上。本综述的结果将与未来研究的结果相结合，并作为针对少数族裔群体成员的指导以及针对医疗保健专业人员和政策制定者的建议进行传播。
PROSPERO注册号：CRD42024579766。
